vTv Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $17 |
Gross Profit | -3 | -9 | -5 | |
EBITDA | -10,338 | -7,718 | -6,494 | -4,415 |
EBIT | -10,340 | -7,721 | -6,503 | -4,437 |
Net Income | -8,698 | -6,046 | -5,092 | -3,634 |
Net Change In Cash | 0 | 0 | 0 | 17 |
Free Cash Flow | -5,222 | -5,095 | -5,687 | -4,825 |
Cash | 98,504 | 25,922 | 31,059 | 36,746 |
Basic Shares | 8,055 | 6,587 | 6,582 | 5,771 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,017 | $9 | $2,018 | $4,005 |
Gross Profit | 1,017 | -90 | 2,018 | 4,005 |
EBITDA | -22,516 | -25,863 | -24,766 | -17,515 |
EBIT | -22,605 | -25,953 | -24,858 | -17,604 |
Net Income | -18,462 | -20,250 | -19,164 | -12,987 |
Net Change In Cash | 1,017 | 9 | 2,018 | 4,005 |
Cost of Revenue | -1,289 | |||
Free Cash Flow | -25,307 | -19,081 | -15,267 | -19,308 |
Cash | 36,746 | 9,446 | 12,126 | 13,415 |
Basic Shares | 5,771 | 2,084 | 1,919 | 1,566 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.08 |
2025-06-30 | -$0.92 |
2025-03-31 | -$0.77 |
2024-12-31 | -$0.55 |
